Stockwell Lynn
SEC CIK 1927032 · EDGAR
BoughtSold
Most active insiders at DMII, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Drugs Made In America Acquisition II LLC | 10% | — | — |
| 2 | Do Catherine | Dir | — | — |
| 3 | Shulgan Myron W. | Dir | — | — |
| 4 | Prasad Sridhar G. | Dir | — | — |
| 5 | Stockwell Lynn | CEO, Exe. COB of Board, Dir, 10% | — | — |
| 6 | Worman Glenn C. | CFO | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2025-10-01 | 2025-09-26 | DMII | Drugs Made In America Acquisition II Corp. | Stockwell Lynn | CEO, Exe. COB of Board, Dir, 10% | P - Purchase | — | +700.0K | 15.07M | +5% | — |
| DI | 2025-10-01 | 2025-09-26 | DMII | Drugs Made In America Acquisition II Corp. | Stockwell Lynn | CEO, Exe. COB of Board, Dir, 10% | S - Sale | — | -7.97M | 6.71M | -54% | — |
| DI | 2025-10-01 | 2025-09-26 | DMII | Drugs Made In America Acquisition II Corp. | Stockwell Lynn | CEO, Exe. COB of Board, Dir, 10% | J - Other | — | -400.0K | 14.68M | -3% | — |
| DI | 2025-02-18 | 2025-02-18 | DMAA | Drugs Made In America Acquisition Corp. | Stockwell Lynn | CEO, Exe. COB of Board, Dir, 10% | P - Purchase | — | +30.0K | 4.19M | +0.7% | — |
| DI | 2025-02-04 | 2025-01-29 | DMAA | Drugs Made In America Acquisition Corp. | Stockwell Lynn | CEO, Executive COB, Dir, 10% | S - Sale | — | -5.70M | 4.16M | -58% | — |
| DI | 2025-02-04 | 2025-01-29 | DMAA | Drugs Made In America Acquisition Corp. | Stockwell Lynn | CEO, Executive COB, Dir, 10% | J - Other | — | -400.0K | 9.86M | -4% | — |
| DI | 2025-02-04 | 2025-01-29 | DMAA | Drugs Made In America Acquisition Corp. | Stockwell Lynn | CEO, Executive COB, Dir, 10% | P - Purchase | — | +400.0K | 10.3K | New | — |
Purchase Sale Sale after option exercise All abbreviations